1 |
Kurozumi A, Okada Y, Mita T, Wakasugi S, Katakami N, Yoshii H, Kanda K, Nishida K, Mine S, Tanaka Y, Gosho M, Shimomura I, Watada H. Associations between continuous glucose monitoring-derived metrics and HbA1c in patients with type 2 diabetes mellitus. Diabetes Research and Clinical Practice 2022. [DOI: 10.1016/j.diabres.2022.109836] [Reference Citation Analysis]
|
2 |
Uemura F, Okada Y, Mita T, Torimoto K, Wakasugi S, Katakami N, Yoshii H, Matsushita K, Nishida K, Inokuchi N, Tanaka Y, Gosho M, Shimomura I, Watada H. Risk factor analysis for type 2 diabetic patients about hypoglycemia using continuous glucose monitoring: Results from a prospective observational study. Diabetes Technol Ther 2022. [PMID: 35049378 DOI: 10.1089/dia.2021.0465] [Reference Citation Analysis]
|
3 |
Tokutsu A, Okada Y, Mita T, Torimoto K, Wakasugi S, Katakami N, Yoshii H, Uryu K, Nishida K, Arao T, Tanaka Y, Gosho M, Shimomura I, Watada H. Relationship between blood glucose variability in ambulatory glucose profile and standardized continuous glucose monitoring metrics: Subanalysis of a prospective cohort study. Diabetes Obes Metab 2021. [PMID: 34498346 DOI: 10.1111/dom.14550] [Reference Citation Analysis]
|